compounds. Deletion strains BY4742Dsnq2, BY4742Dpdr3, and
BY4742Derg6 were treated conformingly with the wild-type strain
treatment, with 0.3 mM molecules. Compounds responsible for the
variation in deletant strain cells generation time, or of the O.D.st
value, or both, were selected for mitochondrial and peroxisomal
investigations.
Res., Fundam. Mol. Mech. Mutagen., 2000, 451, 1; (c) C. Brenner,
GenomeBiology, 2004, 5, 240; (d) D. Auerbach, A. Arnoldo, B. Bogdan,
M. Fetchko and I. Stagljar, Curr. Proteomics, 2005, 2, 1.
4 (a) G. Giaever, P. Flaerty, J. Kumm, M. Proctor, C. Nislow, D. F.
Jarmillo, A. M. Chu, M. I. Jordan, A. P. Arkin and R. W. Davis, Proc.
Natl. Acad. Sci. U. S. A., 2004, 101, 793; (b) P. Y. Lum, C. D. Armour,
S. B. Stepaniants, G. Cavet, M. K. Wolf, J. S. Butler, J. C. Hinshaw,
P. Garnier, G. D. Prestwich, A. Leonardson, P. Garrett-Engele, C. M.
Rush, M. Bard, G. Schimmack, J. W. Phillips, C. J. Roberts and D. D.
Shoemaker, Cell, 2004, 116, 121; (c) A. B. Parsons, R. L. Brost, H.
Ding, Z. Li, C. Zhang, B. Sheikh, G. W. Brown, P. M. Kane, T. R.
Hughes and C. Boone, Nat. Biotechnol., 2004, 22, 62; (d) A. B. Parsons,
A. Lopez, I. E. Givoni, D. E. Williams, C. A. Gray, J. Porter, G. Chua,
R. Sopko, R. L. Brost, C. H. Ho, J. Wang, T. Ketela, C. Brenner, J. A.
Brill, G. E. Fernandez, T. C. Lorenz, G. S. Payne, S. Ishihara, Y. Ohya,
B. Andrews, T. R. Hughes, B. J Frey, T. R. Graham, R. J. Andersen and
C. Boone, Cell, 2006, 126, 611.
5 J. I. Levin, J. M. Chen, L. M. Laakso, M. Du, X. Du, A. M. Venkatesan,
V. Sandanayaka, A. Zask, J. Xu, W. Xu, Y. Zhang and J. S. Skotnicki,
Bioorg. Med. Chem. Lett., 2005, 15, 4345.
6 N. G. Almstead, R. S. Bradley, S. Pikul, B. De, M. G. Natchus, Y. O.
Taiwo, F. Gu, L. E. Williams, B. A. Hynd, M. J. Janusz, C. M. Dunaway
and G. E. Mieling, J. Med. Chem., 1999, 42, 4547.
Fluorescence microscopy
Effects at the mitochondrial level of selected compounds were
observed by mitochondrial membrane potential investigation.
Effects at the peroxisomal level were investigated by GFP-FOX3
microscopic observation. After 4 h of treatment with selected
compounds at 0.3 mM concentration, or without them as a
control, cultured cells were dissolved at 1 ¥ 106 cells ml-1 in 10 mM
HEPES buffer, pH 7.4, containing 5% glucose. Rhodamine B hexyl
ester was added to a final concentration of 100 nM. After 15–
30 min of incubation, the mitochondrial membrane potential was
visualized by fluorescence microscopy (excitation l at 555 nm,
green/emission l at 579 nm, red). Each aliquot was treated with
Calcofluor White (M2R) (Blue) to evidence the cell wall in order
to count total cells. Mitochondrial membrane potential activation
was calculated as percentage of red-fluorescent cells (rhodamine
B hexyl ester-labelled cells) toward total blue-cells (Calcofluor
White-labelled cells) of the same treated culture.
7 C. Lalli, A. Trabocchi, F. Sladojevich, G. Menchi and A. Guarna,
Chem.–Eur. J., 2009, 15, 7871.
8 A. Trabocchi, F. Sladojevich and A. Guarna, Chirality, 2009, 21, 584.
9 (a) M. B. Martins and I. Carvalho, Tetrahedron, 2007, 63, 9923; (b) B.
Nicholson, G. K. Lloyd, B. R. Miller, M. A. Palladino, Y. Kisob, Y.
Hayashib and S. T. C. Neuteboom, Anti-Cancer Drugs, 2006, 17, 25;
(c) A. Folkes, M. B. Roe, S. Sohal, J. Golec, R. Faint, T. Brooks and
P. Charlton, Bioorg. Med. Chem. Lett., 2001, 11, 2589; (d) S. Wang, J.
Golec, W. Miller, S. Milutinovic, A. Folkes, S. Williams, T. Brooks, K.
Hardman, P. Charlton, S. Wren and J. Spencer, Bioorg. Med. Chem.
Lett., 2002, 12, 2367; (e) A. P. Einholm, K. E. Pedersen, T. Wind, P.
Kulig, M. T. Overgaard, J. K. Jensen, J. S. BØdker, A. Christensen, P.
Charlton and P. A. Andreasen, Biochem. J., 2003, 373, 723; (f) D. R.
Houston, B. Synstad, V. G. H. Eijsink, M. J. R. Stark, I. M. Eggleston
and D. M. F. Van Aalten, J. Med. Chem., 2004, 47, 5713; (g) F. Fdhila,
Acknowledgements
Fondazione Roma, CINMPIS, and SYBARIS (Grant Agreement
242220) are acknowledged for financial support. Dr Cristina Faggi
is gratefully acknowledged for the X-ray crystallographic analyses.
V. V
a´zquez, J. L. Sa´nchez and R. Riguera, J. Nat. Prod., 2003, 66,
1299–1301; (h) M. Teixid, E. Zurita, M. Malakoutikhah, T. Tarrag and
E. Giralt, J. Am. Chem. Soc., 2007, 129, 11802.
10 F. Sladojevich, A. Trabocchi and A. Guarna, Org. Biomol. Chem., 2008,
6, 3328.
11 P. Reungpatthanaphong, S. Dechsupa, J. Meesungnoen, C. Loetchuti-
nat and S. Mankhetkorn, J. Biochem. Biophys. Methods, 2003, 57, 1.
12 H. Van Den Bosch, R. B. Schutgens, R. J. Wanders and J. M. Tager,
Annu. Rev. Biochem., 1992, 61, 157.
Notes and references
1 B. R. Stockwell, Nature, 2004, 432, 846.
2 (a) L. M. Mayr and D. Boanic, Curr. Opin. Pharmacol., 2009, 9, 580–
588; (b) I. Stefanini, A. Trabocchi, E. Marchi, A. Guarna and D.
Cavalieri, J. Biol. Chem., 2010, 285, 23477.
13 B. E. Bauer, H. Wolfger and K. Kuchler, Biochim. Biophys. Acta,
Biomembr., 1999, 1461, 217.
3 (a) S. Hoon, R. P. St Onge, G. Giaever and C. Nislow, Trends
Pharmacol. Sci., 2008, 29, 499; (b) M. A. Resnick and B. S. Cox, Mutat.
This journal is
The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 5552–5557 | 5557
©